during the quickly evolving area of cancer therapeutics, being familiar with the intricate mechanisms of Antibody-Drug Conjugates (ADCs) is essential for establishing powerful treatment plans. Probably the most promising ways is using in vitro bystander impact assays, which Participate in a pivotal part in maximizing therapeutic efficacy. These ass